Profile data is unavailable for this security.
About the company
Sunshine Holdings PLC is a Sri Lanka-based company, which is primarily involved in managing a portfolio of investments. The Company's segments include investment and management services, healthcare, agri, consumer goods, and rental business. The investment and management services segment includes managing a portfolio of investments and providing management services. The healthcare segment manufactures, imports, markets pharmaceuticals, nutraceuticals, medical diagnostic equipment and surgical products. It provides medicine in areas such as dermatological, diabetic and cardiovascular medicine, gastrointestinal, and pain management drugs. The agri segment is engaged in the cultivation of oil palm, tea and rubber. The consumer goods segment is engaged in the sale of tea and manufacturing and distribution of confectioneries and exports of tea. The Company's consumer products brands in the tea and sugar confectionary space include Zesta, Watawala, Ran Kahata, Daintee and Milady.
- Revenue in LKR (TTM)56.40bn
- Net income in LKR4.49bn
- Incorporated1973
- Employees1.70k
- LocationSunshine Holdings PLCNo.60 Dharmapala Mw, Colombo 03COLOMBO 03Sri LankaLKA
- Phone+94 114702400
- Fax+94 114716427
- Websitehttps://www.sunshineholdings.lk/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sophia Holdings Co Ltd | 17.11bn | -18.52m | 9.76bn | 193.00 | -- | 1.49 | 13.07 | 0.5706 | -6.53 | -6.53 | 2,548.55 | 725.47 | 1.21 | 10.48 | 7.54 | 46,003,140.00 | -0.1307 | 2.93 | -0.2103 | 5.09 | 37.68 | 35.07 | -0.1082 | 2.32 | 1.57 | 11.17 | 0.4046 | 0.00 | -4.14 | 14.77 | -577.93 | -- | -12.58 | -- |
| Hyuga Primary Care Co Ltd | 16.83bn | 962.26m | 16.17bn | 544.00 | 17.21 | 4.73 | 11.69 | 0.9613 | 67.29 | 67.29 | 1,176.42 | 244.81 | 1.79 | 29.43 | 6.41 | 16,050,780.00 | 10.25 | -- | 16.41 | -- | 22.98 | -- | 5.72 | -- | 1.07 | 59.52 | 0.6145 | -- | 24.46 | -- | 15.19 | -- | -- | -- |
| Healthlead PCL | 15.63bn | 661.44m | 19.00bn | 484.00 | 28.73 | 2.29 | 15.45 | 1.22 | 0.2802 | 0.2802 | 6.62 | 3.52 | 1.33 | 5.22 | 147.76 | -- | 5.64 | 9.00 | 6.60 | 11.24 | 23.13 | 22.77 | 4.23 | 5.46 | 2.45 | 22.96 | 0.2145 | -- | 7.64 | -- | -36.84 | -- | -- | -- |
| Satudora Holdings Co Ltd | 186.19bn | 926.89m | 21.48bn | 1.11k | 22.50 | 1.19 | 6.09 | 0.1154 | 34.80 | 34.80 | 6,987.78 | 656.46 | 2.15 | 6.81 | 33.48 | 87,282,740.00 | 1.10 | 0.797 | 2.20 | 1.49 | 24.84 | 24.39 | 0.5133 | 0.3631 | 0.4631 | 12.17 | 0.6287 | 42.25 | 9.19 | 2.45 | 440.23 | 74.56 | -5.88 | 1.39 |
| Medical System Network Co Ltd | 225.70bn | 3.63bn | 23.97bn | 3.74k | 6.48 | 0.7819 | 2.43 | 0.1062 | 62.66 | 62.66 | 3,926.12 | 519.25 | 1.73 | 11.08 | 35.12 | 31,283,120.00 | 2.80 | 2.19 | 4.30 | 3.35 | 41.64 | 40.83 | 1.62 | 1.33 | 0.5703 | 15.09 | 0.6064 | 23.75 | 5.30 | 3.27 | 15.53 | 32.12 | -7.85 | 3.71 |
| Dingdang Health Technology Group Ltd | 200.91bn | -8.14bn | 29.35bn | 2.51k | -- | 0.3663 | -- | 0.1461 | -0.1623 | -0.1623 | 4.01 | 1.58 | 1.57 | 5.61 | 43.27 | 2,036,852.00 | -6.53 | -55.91 | -9.42 | -82.51 | 32.38 | 32.74 | -4.17 | -35.83 | 1.86 | -- | 0.0766 | -- | 12.19 | 52.72 | 92.03 | -- | 13.40 | -- |
| Sunshine Holdings PLC | 56.40bn | 4.49bn | 33.50bn | 1.70k | 7.46 | 1.80 | 4.88 | 0.594 | 9.13 | 9.13 | 114.65 | 37.82 | 1.33 | 3.45 | 5.04 | 33,119,650.00 | 14.05 | 12.87 | 27.34 | 23.74 | 30.87 | 29.69 | 10.58 | 10.29 | 1.01 | 20.22 | 0.274 | 16.93 | 7.03 | 19.65 | 97.49 | 47.20 | -5.69 | 48.41 |
| Charmacy Pharmaceutical Co Ltd | 184.61bn | 2.13bn | 36.66bn | 834.00 | 17.20 | 1.50 | 10.97 | 0.1986 | 0.5232 | 0.5232 | 45.32 | 5.99 | 1.47 | 5.49 | 4.76 | 5,889,619.00 | 1.70 | 1.79 | 8.48 | 7.99 | 6.91 | 6.16 | 1.15 | 1.24 | 0.7714 | 2.44 | 0.5882 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
| Kimia Farma Tbk PT | 190.44bn | -30.76bn | 67.34bn | 10.71k | -- | 0.6562 | -- | 0.3536 | -297.23 | -304.07 | 1,839.82 | 990.52 | 0.5433 | 2.62 | 4.51 | 892,792,100.00 | -11.23 | -1.82 | -23.01 | -3.22 | 25.74 | 35.14 | -20.67 | -3.08 | 0.3746 | -3.38 | 0.5616 | -- | 7.93 | 3.33 | -737.71 | -- | -9.87 | -- |
| Sipai Health Technology Co, Ltd | 191.04bn | -9.95bn | 148.56bn | 3.25k | -- | 2.41 | -- | 0.7776 | -0.336 | -0.336 | 6.66 | 2.14 | 1.58 | 13.61 | 9.78 | 1,635,929.00 | -7.98 | -- | -13.82 | -- | 9.18 | -- | -5.05 | -- | 1.58 | -- | 0.0386 | -- | 14.39 | -- | 81.34 | -- | -- | -- |
| JZJ Chain Drugstore Corp | 384.72bn | 9.78bn | 165.87bn | 16.65k | 16.73 | 1.45 | -- | 0.4312 | 1.53 | 1.53 | 60.20 | 17.72 | 0.9258 | 2.20 | 20.72 | 559,572.20 | 2.34 | 5.75 | 4.50 | 11.17 | 35.54 | 35.21 | 2.53 | 5.04 | 0.2655 | 2.88 | 0.6563 | 36.62 | 20.84 | 26.84 | 10.72 | 25.41 | 23.62 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Norges Bank Investment Managementas of 30 Jun 2024 | 14.01m | 2.85% |
